Risk factors associated with chronic hepatitis C virus infection: Limited frequency of an unidentified source of transmission

American Journal of Gastroenterology

Volumn 93, Issue 4, 1998, Pages 597-600

  Flamm, Steven L ^a   Parker, Robert A ^b   Chopra, Sanjiv ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; AGE FACTORS; BLOOD TRANSFUSION; COITUS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0032056317     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.171_b.x     Document Type: Article

References (16)

1. 1. Esteban HI, Gonzalez A, Hernandez JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-12.
2. 2. Simon N, Courouce AM, Lemarrec N, et al. A twelve-year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994;46:504-11.
3. 3. Barrera JM, Bruguera M, Ercilla MG, et al. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies for hepatitis C virus and surrogate markers. Ann Intern Med 1991;115:596-600.
4. 4. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assays. N Engl J Med 1991;325:1325-9.
5. 5. Mattsson L, Grillner L, von Sydow M, et al. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Infection 1991;19:309-12.
6. 6. Tremolada F, Casarin C, Tagger A, et al. Antibody to hepatitis virus in post-transfusion hepatitis. Ann Intern Med 1991;114:277-81.
7. 7. Koretz RL, Brezina M, Polito AJ, et al. Non-A, non-B post-transfusion hepatitis: Comparing C and non-C hepatitis. Hepatology 1993;17: 361-5.
8. 8. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
9. 9. Elia GF, Magnani G, Bell L, et al. Incidence of anti-hepatitis in an area of northern Italy. Infection 1991;19:336-9.
10. 10. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
11. 11. Rodriguez M, Riestra S, San Roman F, et al. Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis from different epidemiological categories. Liver 1991;11:129-33.
12. 12. Tassopoulos NC, Hatzakis A, Delladestsima, et al. Role of hepatitis virus in acute non-A, non-B hepatitis in Greece: A 5-year prospective study. Gastroenterology 1992;102:969-72.
13. 13. Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1202-5.
14. 14. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5.
15. 15. Sharara AI, Hunt CM, Hamilton HD. Hepatitis C. Ann Intern Med 1996;125:658-68.
16. 16. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. NEJM 1996;334:1691-6.